The phosphoinositide 3-kinase (PI3K)-Akt pathway is one of the most common dysregulated cancer-associated signalling pathways and it regulates many cellular functions, such as cell proliferation, growth, survival, migration and metabolism; targeting enzymes in this network has become a major goal of cancer drug development 2. The gene discussed is AKT1; the disease is cancer.